Aquestive Therapeutics, Inc. (AQST)
USD 2.37
(-9.54%)
USD 2.37
(-9.54%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.76 Million USD | 17.11% |
| 2022 | 5.78 Million USD | 43.14% |
| 2021 | 4.03 Million USD | 64.08% |
| 2020 | 2.46 Million USD | -13.92% |
| 2019 | 2.85 Million USD | -47.45% |
| 2018 | 5.44 Million USD | 35.55% |
| 2017 | 4.01 Million USD | 39.09% |
| 2016 | 2.88 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 7.73 Million USD | 14.26% |
| 2024 Q2 | 6.96 Million USD | -9.93% |
| 2024 Q3 | 7.02 Million USD | 0.79% |
| 2023 Q3 | 7.07 Million USD | 18.97% |
| 2023 Q4 | 6.76 Million USD | -4.38% |
| 2023 FY | 6.76 Million USD | 17.11% |
| 2023 Q1 | 6.98 Million USD | 20.78% |
| 2023 Q2 | 5.95 Million USD | -14.77% |
| 2022 Q4 | 5.78 Million USD | -14.05% |
| 2022 Q3 | 6.72 Million USD | 34.29% |
| 2022 Q2 | 5 Million USD | 8.19% |
| 2022 FY | 5.78 Million USD | 43.14% |
| 2022 Q1 | 4.62 Million USD | 14.64% |
| 2021 Q4 | 4.03 Million USD | 41.04% |
| 2021 Q2 | 2.83 Million USD | 1.43% |
| 2021 Q3 | 2.86 Million USD | 0.85% |
| 2021 FY | 4.03 Million USD | 64.08% |
| 2021 Q1 | 2.79 Million USD | 13.73% |
| 2020 Q1 | 3.08 Million USD | 7.97% |
| 2020 FY | 2.46 Million USD | -13.92% |
| 2020 Q4 | 2.46 Million USD | -24.09% |
| 2020 Q3 | 3.24 Million USD | 2.17% |
| 2020 Q2 | 3.17 Million USD | 2.79% |
| 2019 Q4 | 2.85 Million USD | -30.67% |
| 2019 Q3 | 4.12 Million USD | -11.25% |
| 2019 Q2 | 4.64 Million USD | -9.54% |
| 2019 Q1 | 5.13 Million USD | -5.59% |
| 2019 FY | 2.85 Million USD | -47.45% |
| 2018 Q1 | 3.85 Million USD | -4.09% |
| 2018 FY | 5.44 Million USD | 35.55% |
| 2018 Q3 | 4.48 Million USD | 3.1% |
| 2018 Q4 | 5.44 Million USD | 21.37% |
| 2018 Q2 | 4.34 Million USD | 12.94% |
| 2017 FY | 4.01 Million USD | 39.09% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 4.01 Million USD | 0.0% |
| 2016 FY | 2.88 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | 33.676% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 93.913% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 93.513% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -18.035% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -18.035% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -262.047% |
| Alpha Teknova, Inc. | 11.59 Million USD | 41.616% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 79.064% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | 87.298% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 89.685% |
| Cosmos Health Inc. | 4.78 Million USD | -41.343% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -735.93% |
| Embecta Corp. | 152.1 Million USD | 95.55% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 41.882% |
| Procaps Group, S.A. | 96.83 Million USD | 93.01% |
| Theratechnologies Inc. | 6.06 Million USD | -11.589% |
| Harrow Health, Inc. | 10.86 Million USD | 37.71% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -148.952% |
| Biofrontera Inc. | 10.9 Million USD | 37.945% |
| DURECT Corporation | 2.21 Million USD | -205.047% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 91.255% |
| Cronos Group Inc. | 30.33 Million USD | 77.689% |
| OptiNose, Inc. | 8.05 Million USD | 15.934% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -676899900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -18.775% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 76.041% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -152.847% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -46.853% |
| Radius Health, Inc. | 278.64 Million USD | 97.571% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -102.467% |
| ProPhase Labs, Inc. | 3.84 Million USD | -76.23% |
| Phibro Animal Health Corporation | 265.91 Million USD | 97.454% |
| Procaps Group S.A. | 96.83 Million USD | 93.01% |
| Alvotech | 74.43 Million USD | 90.906% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.805% |
| Rockwell Medical, Inc. | 5.87 Million USD | -15.296% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 46.418% |
| SIGA Technologies, Inc. | 64.21 Million USD | 89.459% |
| Tilray Brands, Inc. | 252.08 Million USD | 97.315% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 83.069% |
| Shineco, Inc. | 1.58 Million USD | -326.119% |
| PetIQ, Inc. | 159.3 Million USD | 95.751% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 4530.612% |
| Incannex Healthcare Limited | -10.01 Million USD | 167.589% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 82.326% |
| Alimera Sciences, Inc. | 1.87 Million USD | -260.245% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 82.038% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -320.333% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -50.993% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -2561.273% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 34.788% |
| Hempacco Co., Inc. | 2.54 Million USD | -166.221% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 90.906% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 85.837% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 89.428% |
| Currenc Group, Inc. | 732.91 Thousand USD | -823.577% |
| Kamada Ltd. | 87.74 Million USD | 92.286% |
| Indivior PLC | 141.79 Million USD | 95.226% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -1304.823% |
| Flora Growth Corp. | 8.5 Million USD | 20.44% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -2561.273% |
| Evolus, Inc. | 10.99 Million USD | 38.452% |
| HUTCHMED (China) Limited | 50.25 Million USD | 86.531% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 93.604% |
| Akanda Corp. | 1.28 Million USD | -425.995% |